MetaVia Inc. (MTVA) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, MetaVia reported revenue of $0. Net income was -$13.0M, or -$7.35 per diluted share. Operating activities generated -$15.7M of cash, leaving -$15.7M of free cash flow. At fiscal year end, MetaVia held $11.1M in total assets against $5.8M in total liabilities, including $10.3M of cash and equivalents.
Open the full interactive MetaVia financials → Quarterly statements, key ratios, valuation history and price charts.
MetaVia Key Stats
| Share Price | $1.43 |
|---|---|
| Market Cap | $8.5M |
| 52-Week Range | $0.97 – $11.99 |
| Shares Outstanding | 5.9 million (basic, 2026 Q2) |
MetaVia Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Goods Sold | $29.7M | $15.3M | $19.6M | $15.9M | $28.8M | — |
| Gross Profit | -$29.7M | -$15.3M | -$19.6M | -$15.9M | -$28.8M | — |
| Operating Income | -$29.7M | -$15.3M | -$19.6M | -$15.9M | -$28.8M | -$13.7M |
| Pre-Tax Income | -$29.7M | -$15.3M | -$14.0M | -$12.5M | -$27.6M | -$13.0M |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$29.7M | -$15.3M | -$14.0M | -$12.5M | -$27.6M | -$13.0M |
| Diluted EPS | -$4831.20 | -$1742.40 | -$477.84 | -$27.06 | -$39.16 | -$7.35 |
MetaVia Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$3.4M | -$1.9M | -$3.8M | -$5.3M |
| Diluted EPS | -$1.54 | -$1.09 | -$0.79 | -$0.90 |
MetaVia Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.1M | $16.4M | $33.4M | $22.4M | $16.0M | $10.3M |
| Current Assets | $10.7M | $16.6M | $33.5M | $22.5M | $16.1M | $10.9M |
| Total Assets | $11.0M | $16.8M | $33.5M | $22.8M | $16.3M | $11.1M |
| Current Liabilities | $3.7M | $2.2M | $11.8M | $6.0M | $8.3M | $5.6M |
| Total Liabilities | $3.8M | $2.2M | $11.8M | $6.1M | $8.3M | $5.8M |
| Shareholders' Equity | $7.2M | $14.6M | $21.8M | $16.7M | $7.9M | $5.3M |
MetaVia Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$10.8M | -$15.1M | -$11.7M | -$10.8M | -$24.7M | -$15.7M |
| Cash From Investing | $69,000 | -$586,000 | $8,000 | -$50,000 | -$8,000 | -$2,000 |
| Cash From Financing | $6.9M | $22.0M | $28.7M | -$80,000 | $18.3M | $10.0M |
| Free Cash Flow | -$10.8M | -$15.1M | -$11.7M | -$10.8M | -$24.7M | -$15.7M |
Figures from MetaVia's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full MetaVia financials page for every line item.
MetaVia Company Profile
| Ticker | MTVA |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Cambridge, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001638287 |
Frequently Asked Questions
What was MetaVia's revenue in fiscal 2025?
MetaVia (MTVA) reported revenue of $0 for fiscal 2025.
What is MetaVia's annual revenue history?
MetaVia's annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $0; 2024: $0; 2025: $0.
What was MetaVia's net income in fiscal 2025?
MetaVia reported net income of -$13.0M for fiscal 2025.
What was MetaVia's earnings per share (EPS) in fiscal 2025?
MetaVia's diluted EPS was -$7.35 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did MetaVia generate in fiscal 2025?
MetaVia generated -$15.7M of free cash flow in fiscal 2025.
What was MetaVia's revenue last quarter?
In its most recent reported quarter (2026 Q2), MetaVia reported revenue of $0.
How many shares of MetaVia are outstanding?
MetaVia reported a weighted average of 5.9 million basic shares outstanding in 2026 Q2.
What is MetaVia's market cap?
Based on its latest closing price, MetaVia (MTVA) has a market capitalization of about $8.5M.
When does MetaVia's fiscal year end?
MetaVia's fiscal year end, as registered with the SEC, is December 31.
Where is MetaVia headquartered?
MetaVia lists its business address in Cambridge, Massachusetts in its SEC filings.